FDA Brief

Warning letters Devices

FDA warning letter to

Vivera Pharmaceuticals, Inc.

Issued Jul 26, 2021Posted Aug 10, 2021Center for Devices and Radiological Health

Adulterated and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19). We haven't summarized this letter yet. Read it on fda.gov.

Vivera Pharmaceuticals, Inc.'s FDA history

  1. Vivera Pharmaceuticals, Inc.

    Adulterated and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

Full company page